摘要
2005年,北京市教委在首都医科大学建立了多肽及小分子药物北京市重点实验室。本文分析了重点实验室在心脑血管药物研究、抗肿瘤药物研究和抗骨质疏松药物研究中的革新意识、钻研学问和训练人才的基本状况。
Beijing Area Major Laboratory of Peptide and Small Molecular Drugs has been established for five years. This paper reports the progress of this laboratory in the discovery of cardio-cerebral,anti-cancer and anti-osteoporosis drugs via the refining of the ideal,deepgoing of the research and training of the successor.
出处
《首都医科大学学报》
CAS
北大核心
2010年第4期509-513,共5页
Journal of Capital Medical University